Genomic profiling using the illumina human HT-12 expression BeadChip V4
Total RNA was isolated using the RNeasy Mini kit (Qiagen) following the manufacturer's instructions. 1 μg RNA was amplified and labeled with an Illumina TotalPrep RNA amplification kit (Life Technologies, Ambion), and hybridized according to the manufacturer's protocol (Illumina GeneExpression Direct Hyb; illumina, San Diego, USA). Arrays were read by an Illumina Bead Chip Reader, and data were normalized by quantile normalization in GenePattern (http:// genepattern. broadinstitute.org/gp/pages/index.jsf). The ratios of gene expression in OVCAR-3 cells treated for 24 h with paclitaxel versus untreated cells were determined, and the Top 30 up-and downregulated kinases were tabulated.
High-throughput siRNA-transfection
The siRNA library targeting 711 human kinases (4 siRNAs/well/gene) was purchased from Dharmacon. OVCAR-3 cells were transfected by the reverse method (simultaneous seeding and siRNA-transfection). Briefly, Lipofectamine RNAiMAX (Invitrogen) was diluted in serum-reduced medium (Opti-MEM, Invitrogen) and plated in white, clear-bottom half-area 96 well-plates (Greiner Bio-One). siRNAs were pre-diluted in siRNADilution buffer (Dharmacon) and added to a final concentration of 20 nM. Plates containing the siRNAlipid mix were spun down (1,000 rpm for 10 seconds) and complexes were allowed to form for 20 min at room temperature. Meanwhile OVCAR-3 cells were trypsinized, collected in fresh medium and counted. Cell suspension (2.100 cells / 40 μL) was prepared in RPMI completed with 12.5% FCS and added to a final volume of 50 μL per well. Each plate included the following controls: Medium alone (background), untreated cells (basal level), 20 nM siGlo Red Transfection Indicator (transfection control, Dharmacon), 20 nM siPLK1 (test efficiency and consistency, Sigma) and 1 μM Campthotecin (apoptosis, cell death and consistency, Enzo Life Sciences). Each plate was analyzed in triplicate.
Antibodies and chemicals
Primary antibodies were obtained from the following sources: PLK1 (05-844), phospho-Histone H3 (Ser10) (05806) from Millipore; Cyclin B1 (GNS1) from Santa Cruz; PARP (9542), phospho-Aurora B (2914), BCL-X L (2762), Caspase-3 (9668) and Cyclin E (4129) from Cell Signaling; BAK (AMO3-100UG), BAX (B8429) and MCL-1 (ADI-AAP-240-D) from Enzo, Securin (ab3305), pBCL-X L S62 (ab30655) and EndoG (ab9647) from Abcam, FBW7 (40-1500) Invitrogen, β-Actin (A2228-100UL) from Sigma-Aldrich served as loading control.
Secondary antibodies for western blot analysis against Rabbit (NA934V) and Mouse (NXA931) IgG were obtained from GE Healthcare. Secondary antibodies used for immunofluorescence staining were obtained from Dako (F0313). Paclitaxel (T7402) was purchased from Sigma-Aldrich, BI6727 (BYT-ORB181049) Selleckchem, propidium iodide (440300250) Acros Organics, RNase A (1007885) Qiagen, PE Annexin V (556421), 7AAD (21-68981E) BD Biosciences and β-Nerve-growth factor (G514A) Promega.
Phospho-histone H3 (Ser10) staining
Cells were treated with paclitaxel, BI6727 or both, trypsinized, fixed using 4% paraform-aldehyde (PFA, Sigma Aldrich) in PBS containing 0.01% Triton-X-100 and washed with PBS-T before adding a phospho-Histone H3 (Ser10) specific antibody. Staining was performed for 1 h at 37°C. Secondary staining was done for 30 min using a FITC-coupled antibody. Fractions of mitotic cells were quantified using a FACS Calibur and Cellquest Pro software (both BD Biosciences).
Western blot analysis
Protein extracts of cells were prepared by lysis in RIPA buffer (Sigma) supplemented with protease inhibitors (Complete protease inhibitor cocktail, Roche). Protein extracts (25 μg) were separated by SDS-PAGE and transferred onto PVDF membranes using the TransBlot Turbo Transfer System (BioRad). After blocking with 5% BSA in PBS with 0.1% Tween-20 for 30 min, the membrane was incubated with primary antibodies for 1 h at room temperature. HRP-linked secondary antibodies were incubated 30 min at room temperature followed by ECL detection (ECL Chemiluminescent Western Blot Substrate, Pierce).
Membrane potential
OVCAR-3 cells were trypsinized, washed in PBS and centrifuged at 700g for 5 min. The cell pellets were incubated with 10 nM DiOC 6 (3) in fresh medium at 37°C for 30 min in the dark. After incubation, cells were washed twice and resuspended in PBS and assayed using flow cytometry. The fluorescence intensity of DiOC 6 (3) was measured and calculated by BD FACS CellQuest Pro software.
Colony formation assay
Cells were treated with paclitaxel, BI6727 or both overnight followed by seeding predefined numbers in 6-well plates. Colonies were fixed using 70% EtOH and stained with Coomassie Brilliant Blue. The numbers of grown colonies were counted and images were taken using AxioObserver Z1 microscope (Zeiss) as well as the ChemiDoc MP system (BioRad).
Nerve growth factor (NGF)-induced neurite outgrowth assay.
Undifferentiated PC-12 cells were pretreated for 5 days by adding β-NGF (NGF from mouse source) (Promega) to a final concentration of 50 ng/ml, trypsinized, washed using phosphate-buffered saline (PBS), centrifuged and plated in 12-well culture chambers (Costar, Nuclepore). Optimal adherence and neurite formation required precoating the cell culture plastic using collagen I (Gibco), followed by washing with PBS. Differentiated PC-12 cells were co-incubated with paclitaxel, BI6727 or both together with 10 ng/ml β-NGF. Subsequently, cells expressing neuronal like structures were examined using an AxioObserver Z1 microscope (Zeiss). Images were taken using an AxioCam MRm camera and analyzed using ImageJ Fiji.
To discriminate specific neurotoxicity from general cytotoxicity, the analysis was performed on the basis of the fraction of neurite-forming cells instead of the absolute number of cells. The results, therefore, are given as percentage of cells expressing neurites. 50 symbolize the concentrations of drug A/B necessary to achieve 50% growth inhibition in single administration. A combination index >1 indicates an antagonistic effect, whereas an index =1 displays an additive and an index <1 a synergistic effect [2] .
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